GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » PS Ratio

Stella Pharma (TSE:4888) PS Ratio : 42.12 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Stella Pharma's share price is 円348.00. Stella Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円8.26. Hence, Stella Pharma's PS Ratio for today is 42.12.

The historical rank and industry rank for Stella Pharma's PS Ratio or its related term are showing as below:

TSE:4888' s PS Ratio Range Over the Past 10 Years
Min: 28.65   Med: 84.59   Max: 396.59
Current: 42.13

During the past 5 years, Stella Pharma's highest PS Ratio was 396.59. The lowest was 28.65. And the median was 84.59.

TSE:4888's PS Ratio is ranked worse than
77.74% of 1002 companies
in the Biotechnology industry
Industry Median: 9.495 vs TSE:4888: 42.13

Stella Pharma's Revenue per Sharefor the three months ended in Dec. 2023 was 円1.48. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was 円8.26.

During the past 12 months, the average Revenue per Share Growth Rate of Stella Pharma was 24.30% per year.

Back to Basics: PS Ratio


Stella Pharma PS Ratio Historical Data

The historical data trend for Stella Pharma's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma PS Ratio Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
PS Ratio
- - - 169.19 48.78

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.20 48.78 38.70 33.20 34.50

Competitive Comparison of Stella Pharma's PS Ratio

For the Biotechnology subindustry, Stella Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Pharma's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's PS Ratio distribution charts can be found below:

* The bar in red indicates where Stella Pharma's PS Ratio falls into.



Stella Pharma PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Stella Pharma's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=348.00/8.262
=42.12

Stella Pharma's Share Price of today is 円348.00.
Stella Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円8.26.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Stella Pharma  (TSE:4888) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Stella Pharma PS Ratio Related Terms

Thank you for viewing the detailed overview of Stella Pharma's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma (TSE:4888) Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma (TSE:4888) Headlines

No Headlines